• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ANI Pharmaceuticals Inc

+ Add to Watchlist

ANIP:US

54.1600 USD 1.6400 2.94%

As of 20:10:00 ET on 12/19/2014.

Snapshot for ANI Pharmaceuticals Inc (ANIP)

Open: 55.6800 Day's Range: 53.2000 - 56.3400 Volume: 1,150,592
Previous Close: 55.8000 52wk Range: 16.7200 - 61.4300 1-Yr Rtn: +217.65%

Stock Chart for ANIP

No chart data available.
  • ANIP:US 54.1600
  • 1D
  • 1M
  • 1Y
55.8000
Interactive ANIP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANIP

Current P/E Ratio (ttm) 50.6547
Estimated P/E(12/2014) 39.5328
Relative P/E vs. SPX 2.7646
Earnings Per Share (USD) (ttm) 1.0692
Est. EPS (USD) (12/2014) 1.3700
Est. PEG Ratio -
Market Cap (M USD) 613.60
Shares Outstanding (M) 11.32
30 Day Average Volume 371,266
Price/Book (mrq) 6.1670
Price/Sale (ttm) 12.4847
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANIP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANIP

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company develops, manufactures and markets branded and generic prescription pharmaceuticals. ANI manufactures oral solid dose products, as well as liquids and topicals.

Robert E Brown JrChairmanArthur S PrzybylPresident/CEO
Charlotte C ArnoldVP/CFORobert SchrepferVP:Business Development
More Company Profile & Key Executives for ANIP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil